A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.
A Randomized, Double-Blind Comparison of Apadenoson and Adenosine to Treadmill Exercise Stress for Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Sponsor: Forest Laboratories
Terminated
Business decision to end program
Other terminated trials from Forest Laboratories
Other Coronary Artery Disease trials with similar outcome
Listed as NCT00380198, this PHASE3 trial focuses on Coronary Artery Disease and remains terminated or withdrawn. Sponsored by Forest Laboratories, it has been updated 6 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Forest Laboratories
For direct contact, visit the study record on ClinicalTrials.gov .